Home/Filings/4/0001179929-24-000037
4//SEC Filing

Keim Mark Lowell 4

Accession 0001179929-24-000037

CIK 0001179929other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:38 PM ET

Size

22.4 KB

Accession

0001179929-24-000037

Insider Transaction Report

Form 4
Period: 2024-02-12
Keim Mark Lowell
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-02-12$385.80/sh1,203$464,11140,462 total
  • Sale

    Common Stock

    2024-02-12$388.61/sh1,264$491,20850,267 total
  • Sale

    Common Stock

    2024-02-12$387.94/sh4,251$1,649,12446,016 total
  • Sale

    Common Stock

    2024-02-12$387.00/sh4,351$1,683,83741,665 total
  • Sale

    Common Stock

    2024-02-12$384.58/sh1,815$698,00938,647 total
  • Sale

    Common Stock

    2024-02-12$383.82/sh2,116$812,16536,531 total
Footnotes (7)
  • [F1]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $388.430 to $388.805. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
  • [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $387.430 to $388.415. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
  • [F3]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $386.43 to $387.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
  • [F4]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $385.300 to $386.155. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
  • [F5]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.19 to $385.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
  • [F6]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.17 to $384.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
  • [F7]Amount of shares beneficially owned reflects an additional 102 shares arising from a calculation error in connection with the payment of withholding taxes related to a vesting event on January 10, 2020.

Issuer

MOLINA HEALTHCARE, INC.

CIK 0001179929

Entity typeother

Related Parties

1
  • filerCIK 0001690677

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:38 PM ET
Size
22.4 KB